Target lesion response predicts survival of patients with hepatocellular carcinoma retreated with transarterial chemoembolization

Publisher： John Wiley & Sons Inc

E-ISSN： 1478-3231|36|10|1516-1524

ISSN： 1478-3223

Source： LIVER INTERNATIONAL (ELECTRONIC), Vol.36, Iss.10, 2016-10, pp. : 1516-1524

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy of Sorafenib in Intermediate-Stage Hepatocellular Carcinoma Patients Refractory to Transarterial Chemoembolization

By  

Oncology, Vol. 87, Iss. 6, 2014-09 ,pp. : 330-341

Karger

Access to resources Recommend Favorite

Evaluation of ART Scores for Repeated Transarterial Chemoembolization in Japanese Patients with Hepatocellular Carcinoma

By  

Oncology, Vol. 89, Iss. 2, 2015-0 ,pp. : 4-10

Karger

Access to resources Recommend Favorite

Post‐embolization syndrome as an early predictor of overall survival after transarterial chemoembolization for hepatocellular carcinoma

By  

HPB, Vol. 17, Iss. 12, 2015-12 ,pp. : 1137-1144

John Wiley & Sons Inc

Access to resources Recommend Favorite

Impact of multiple transarterial chemoembolization treatments on hepatocellular carcinoma for patients awaiting liver transplantation

By  

LIVER TRANSPLANTATION, Vol. 21, Iss. 2, 2015-02 ,pp. : 248-257

John Wiley & Sons Inc

Access to resources Recommend Favorite

Transarterial chemoembolization with drug‐eluting beads is effective for the maintenance of the Milan‐in status in patients with a small hepatocellular carcinoma

By  

LIVER TRANSPLANTATION, Vol. 21, Iss. 10, 2015-10 ,pp. : 1259-1269

John Wiley & Sons Inc

Access to resources Recommend Favorite